Skip to content

Clinical trials

Phase 3 Inflammation trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 3 Country / region: United States Clear all

68 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20041
20051
20061
20075
20082
20093
201011
20115
20126
20133
20145
20152
20162
20172
20185
20204
20212
20221
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed56
Terminated7
Recruiting2
Active, not recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bausch & Lomb Incorporated11
Amgen4
Emory University4
Sirion Therapeutics, Inc.4
Kala Pharmaceuticals, Inc.2
Population Health Research Institute2
Salvat2
Sun Pharmaceutical Industries Limited2
Xigen SA2
Alcon Research1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation68
Pain17
Cataract15
Arthritis5
Cardiovascular Diseases5
Arthritis, Psoriatic4
Pathologic Processes4
Psoriasis4
Skin Diseases4
Atrial Fibrillation3

Trials

Showing 1 to 25 of 68. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.